AAQ1 — Aap Implantate AG Cashflow Statement
0.000.00%
Last trade - 00:00- €20.17m
- €21.80m
- €11.48m
- 12
- 25
- 57
- 19
Annual cashflow statement for Aap Implantate AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.4 | -8.94 | -2.52 | -2.56 | -5.13 |
| Depreciation | |||||
| Non-Cash Items | -0.297 | 0.547 | 0.044 | -0.812 | -0.165 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.841 | 1.59 | -1.84 | -0.189 | 0.684 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.77 | -3.67 | -2.47 | -1.89 | -2.99 |
| Capital Expenditures | -1.69 | -0.414 | -0.523 | -0.485 | -0.406 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.99 | 0.274 | 0.678 | 0.016 | 0.02 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.302 | -0.14 | 0.155 | -0.469 | -0.386 |
| Financing Cash Flow Items | 2.06 | -0.194 | -0.321 | -0.249 | -0.329 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.13 | 1.77 | 3.53 | 0.475 | 4.42 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.33 | -2.05 | 1.23 | -1.88 | 1.04 |